F. SMED ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Bankruptcy risk for industry  2.9% 2.9% 2.9% 2.9% 2.9%  
Bankruptcy risk  5.3% 6.4% 6.0% 3.9% 5.0%  
Credit score (0-100)  43 37 37 50 43  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Net sales  0 0 0 0 0  
Gross profit  220 213 194 291 374  
EBITDA  53.8 57.9 44.8 106 190  
EBIT  11.2 31.0 17.9 83.2 164  
Pre-tax profit (PTP)  10.9 30.8 16.4 82.7 163.3  
Net earnings  8.4 22.6 13.9 64.5 127.3  
Pre-tax profit without non-rec. items  10.9 30.8 16.4 82.7 163  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Tangible assets total  226 199 172 182 361  
Shareholders equity total  132 103 94.0 145 213  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  296 244 283 385 456  

Net Debt  -3.3 -1.6 -58.1 -108 -6.1  
 
See the entire balance sheet

Volume 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  220 213 194 291 374  
Gross profit growth  -20.9% -3.3% -8.7% 49.7% 28.9%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  296 244 283 385 456  
Balance sheet change%  -14.7% -17.5% 16.0% 35.9% 18.7%  
Added value  53.8 57.9 44.8 110.1 189.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -70 -54 -54 -12 153  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.1% 14.6% 9.2% 28.6% 43.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  3.5% 11.5% 6.8% 24.9% 38.9%  
ROI %  7.1% 26.4% 18.2% 69.6% 86.3%  
ROE %  5.4% 19.2% 14.2% 54.0% 71.0%  

Solidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Equity ratio %  44.8% 42.3% 33.2% 37.7% 46.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -6.2% -2.8% -129.6% -101.9% -3.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  15.9% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Quick Ratio  0.3 0.2 0.5 0.8 0.4  
Current Ratio  0.4 0.3 0.6 0.9 0.5  
Cash and cash equivalent  3.3 1.6 58.1 107.5 6.1  

Capital use efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -93.1 -95.6 -73.4 -21.3 -113.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales / employee  0 0 0 0 0  
Added value / employee  54 58 45 110 190  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  54 58 45 106 190  
EBIT / employee  11 31 18 83 164  
Net earnings / employee  8 23 14 65 127